JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Omnicell Inc

Fechado

SetorSaúde

36.8 -5.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

36.76

Máximo

37.26

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

113.256

84.243

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+57% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

834M

2.2B

Abertura anterior

42.32

Fecho anterior

36.8

Sentimento de Notícias

By Acuity

73%

27%

317 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de fev. de 2026, 23:57 UTC

Conversa de Mercado

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 de fev. de 2026, 23:47 UTC

Conversa de Mercado

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 de fev. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 de fev. de 2026, 23:34 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 de fev. de 2026, 23:34 UTC

Conversa de Mercado

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 de fev. de 2026, 23:26 UTC

Conversa de Mercado

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 de fev. de 2026, 21:43 UTC

Conversa de Mercado

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 de fev. de 2026, 21:16 UTC

Conversa de Mercado

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 de fev. de 2026, 21:15 UTC

Conversa de Mercado

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 de fev. de 2026, 09:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

7 de fev. de 2026, 09:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

7 de fev. de 2026, 05:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

7 de fev. de 2026, 02:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Big Money, High Anxiety -- Barrons.com

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

6 de fev. de 2026, 21:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 de fev. de 2026, 21:22 UTC

Conversa de Mercado

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 de fev. de 2026, 21:17 UTC

Ganhos

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 de fev. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de fev. de 2026, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 de fev. de 2026, 21:13 UTC

Ganhos

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 de fev. de 2026, 21:13 UTC

Ganhos

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 de fev. de 2026, 21:04 UTC

Conversa de Mercado

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 de fev. de 2026, 20:34 UTC

Ganhos

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

57% parte superior

Previsão para 12 meses

Média 58.2 USD  57%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

317 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat